Search Results 1961-1970 of 20183 for Receptor

1. A Study To Investigate The Efficacy And Safety Of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib In Adults With Relapsed/Refractory Mantle Cell Lymphoma - Mayo Clinic

   * Prior autologous stem cell transplantation or chimeric antigen receptor T-cell therapy within 3 months before first dose of study drug * Prior allogeneic ...

2. Zanzalintinib Versus Everolimus In Participants With Locally Advanced Or Metastatic Neuroendocrine Tumors - Mayo Clinic

   * Prior treatment with a vascular endothelial growth factor receptor (VEGFR) -targeting tyrosine kinase inhibitor or a mammalian target of rapamycin (mTOR) ...

3. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

   ... receptor pathway inhibitor (ARPI) and progressed during or after at least 8 weeks of treatment Exclusion Criteria: The main exclusion criteria include but ...

4. Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments - Mayo Clinic

   ... receptor-2 positive cells found in peripheral blood, some of which may be circulating endothelial progenitor cells. Levels of such cells are suppressed in a ...

5. Impact Of Aromatase Inhibitor Therapy On Glucose Homeostasis And Diabetes Risk - Mayo Clinic

   * Post-menopausal women with hormone receptor positive breast cancer or ductal carcinoma in situ (DCIS). Post-menopause will be defined as women who ...

6. I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer - Mayo Clinic

   Breast Receptor status: Any tumor ER/PgR status, any HER2/neu status as measured by local hospital pathology laboratory, and meets any tumor assay profile ...

7. The new kids on the block - Mayo Clinic News Network

   D., presented the results of his project aimed to improve immune-stimulating chimeric antigen receptor-T cell therapy (CAR T cell therapy) for acute myeloid ...

8. Open-Label Safety Study Of ADS-5102 In PD Patients With LID - Mayo Clinic

   ... receptor occupancy of short- and long-acting oral methylphenidate. Spencer ... According to recent reports, treatment with the NMDA receptor antagonist amantadine ...

9. Study of Hemodynamic-GUIDEd Management of Heart Failure - Mayo Clinic

   Intolerance to all neuro-hormonal antagonists (i.e., intolerance to angiotensin converting enzyme-inhibitors (ACE-I), angiotensin receptor blockers (ARB) ...

10. Gastroenterology and Hepatology - Clinical trials

    Scottsdale/Phoenix, Ariz. The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy ...